Screener
Sotera Health SHC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Sotera Health in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Sotera Health’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001822479-26-000047
FAQ
- What is Sotera Health's cash & equivalents?
- Sotera Health (SHC) reported cash & equivalents of $356.72M in Q2 2026.
- How has Sotera Health's cash & equivalents changed year-over-year?
- Sotera Health's cash & equivalents increased by 7.3% year-over-year, from $332.44M to $356.72M.
- What is the long-term trend for Sotera Health's cash & equivalents?
- Over 5 years (2020 to 2025), Sotera Health's cash & equivalents has grown at a 27.5% compound annual growth rate (CAGR), from $102.45M to $344.62M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Sotera Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude